Keum et al. [4] proposed a panel for the stratification of CRC patients consisting on mutations in KRAS, BRAF and PIK3CA and the expression of IRS1, IRS2, FASN, and CTNNB1 as these genes are implicated in the insulin signaling pathway. The gene discussed is KRAS; the disease is colorectal carcinoma.